The RADIO CARE joint Lab: a Gustave Roussy and LXRepair's partnership for personalized radiotherapy of cancer
PARIS and GRENOBLE, FRANCE – October 21st, 2021 – LXRepair, a pioneer in personalized radiotherapy with functional assays measuring DNA repair to predict treatment response, with a clinical proof-of-concept of radiotoxicity prediction in breast and prostate cancer, and Gustave Roussy, Europe's leading cancer center, announced today the launch of a joint laboratory to improve the personalization of radiotherapy. Read more…